![Thomas Stratford](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Stratford
Directeur/Membre du Conseil chez Kyowa Kirin International Plc
Postes actifs de Thomas Stratford
Sociétés | Poste | Début | Fin |
---|---|---|---|
Kyowa Kirin International Plc
![]() Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Directeur/Membre du Conseil | - | - |
Directeur Général | 07/09/2011 | - |
Historique de carrière de Thomas Stratford
Anciens postes connus de Thomas Stratford
Sociétés | Poste | Début | Fin |
---|---|---|---|
GSK PLC | Corporate Officer/Principal | - | - |
Formation de Thomas Stratford
King's College London | Doctorate Degree |
Statistiques
Internationale
Royaume-Uni | 4 |
Opérationnelle
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
GSK PLC | Health Technology |
Entreprise privées | 1 |
---|---|
Kyowa Kirin International Plc
![]() Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Thomas Stratford
- Expérience